Bismuth Subcitrate Potassium, Metronidazole, Tetracycline
Nitroimidazole Antimicrobial class · 2 generic manufacturers · 2 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Bismuth Subcitrate Potassium, Metronidazole, Tetracycline used for?
Bismuth Subcitrate Potassium, Metronidazole, Tetracycline is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Bismuth Subcitrate Potassium, Metronidazole, Tetracycline?
Yes. 2 ANDAs filed at FDA, 2 generic manufacturers currently shipping.
How much does my plan pay for Bismuth Subcitrate Potassium, Metronidazole, Tetracycline?
Across 329 Part D plans, Bismuth Subcitrate Potassium, Metronidazole, Tetracycline averages $2.40/unit (NADAC). Lowest available: $2.40/unit. Highest in distribution: $2.40/unit.
Is Bismuth Subcitrate Potassium, Metronidazole, Tetracycline on the FDA shortage list?
No. Bismuth Subcitrate Potassium, Metronidazole, Tetracycline is not currently on the FDA Drug Shortage Database.
3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.